We've done exceptionally well with our biotech recommendations here at Private Briefing.
And a lot of you who've acted on those picks have been telling us that you've done well, too.
This is premium content for Private Briefing subscribers only.
This Baby Biotech Firm Is Making a $400 Million Market Move
Galapagos NV (Nasdaq ADR: GLPG) is at it again.
The Mechelen, Belgium-based Galapagos recently announced plans for a global offering of common stock.